Core Insights - BridgeBio Pharma, Inc. is set to release its second quarter financial results and business updates on August 5, 2025, after market close [1] - A conference call will be held at 4:30 pm ET on the same day to discuss the financial results and program updates [1] Company Overview - BridgeBio Pharma, Inc. is a biopharmaceutical company focused on discovering, creating, testing, and delivering transformative medicines for genetic diseases [3] - The company was founded in 2015 and has a pipeline that includes programs from early science to advanced clinical trials [3] - BridgeBio's team consists of experienced professionals dedicated to applying advances in genetic medicine to benefit patients [3]